CLINICAL IMPACT OF PREEXISTING AND DE NOVO ANTIENDOTHELIAL CELL ANTIBODIES DETECTED BY A NEW INDIRECT IMMUNOFLUORESCENCE ASSAY IN KIDNEY AND PANCREAS TRANSPLANTATION